Open access
Sep 2026
Five-Year Follow-Up of Transcatheter Aortic Valve Replacement With Self-Expanding Intra-Annular Versus Commercially Available Valves.
In patients at high or extreme surgical risk, TAVR with the self-expanding intra-annular transcatheter heart valve had similar 5-year overall survival, stroke rates, and valve function compared with commercially available valves.
Raj R. Makkar, Wen Cheng, Ron Waksman et al.
· JACC: Cardiovascular Interve... · 0 citations